Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
RCUS
$17.43
-1.91%
RCUS
· Arcus Biosciences, Inc.
$17.43
-0.34 (-1.91%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$2.51B
Shares
143.99M
Volume · Nov 13
1.14M
Avg daily vol (3M)
1.84M
All webcasts
Earnings call · FY2024 Q2
Arcus Biosciences, Inc. (RCUS) Q2 2024 Earnings Call
Revenue
$39.00M
+34.5% YoY
Diluted EPS
-$1.02
Net income
-$93.00M
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 8, 2024.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Cash, cash equivalents and marketable securities
end of 2024
|
$885M – $925M | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 8, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 8, 2024 · complete as-filed document